BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2300259)

  • 1. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance.
    Dyck PJ
    Neurology; 1990 Feb; 40(2):327-8. PubMed ID: 2300259
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy.
    Cook D; Dalakas M; Galdi A; Biondi D; Porter H
    Neurology; 1990 Feb; 40(2):212-4. PubMed ID: 2153942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
    Vera-Ramirez M; Charlet M; Parry GJ
    Neurology; 1992 Aug; 42(8):1636-7. PubMed ID: 1641167
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies.
    Glass JD; Cornblath DR
    Curr Opin Neurol; 1994 Oct; 7(5):393-7. PubMed ID: 7804458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of neurologic function in chronic inflammatory demyelinating polyradiculoneuropathy following intravenous gamma-globulin infusion.
    Albala M; McNamara ME; Sokol M; Wyshock E
    Arch Neurol; 1987 Mar; 44(3):248-9. PubMed ID: 2435270
    [No Abstract]   [Full Text] [Related]  

  • 6. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2010 Sep; 15(3):185-95. PubMed ID: 21040140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Rossi F; Brand A; van Lint M; Vermeulen M; Kazatchkine MD
    J Neuroimmunol; 1990; 29(1-3):57-64. PubMed ID: 2211989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy.
    Dalakas MC; Quarles RH; Farrer RG; Dambrosia J; Soueidan S; Stein DP; Cupler E; Sekul EA; Otero C
    Ann Neurol; 1996 Nov; 40(5):792-5. PubMed ID: 8957021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin.
    Vedanarayanan VV; Kandt RS; Lewis DV; DeLong GR
    Neurology; 1991 Jun; 41(6):828-30. PubMed ID: 2046925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VIM thalamic stimulation for tremor in a patient with IgM paraproteinaemic demyelinating neuropathy.
    Růzicka E; Jech R; Zárubová K; Roth J; Urgosík D
    Mov Disord; 2003 Oct; 18(10):1192-5. PubMed ID: 14534927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.
    van Doorn PA; Brand A; Strengers PF; Meulstee J; Vermeulen M
    Neurology; 1990 Feb; 40(2):209-12. PubMed ID: 2405291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapy of demyelinating neuropathies.
    Ruderman MI; Turkewitz LJ
    Mt Sinai J Med; 1985 Jun; 52(6):490-5. PubMed ID: 2991757
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
    Bromberg MB; Feldman EL; Albers JW
    Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-D immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy.
    Vermeulen M; van Schaik IN; Brand A
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):383-4. PubMed ID: 7897433
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Cornblath DR; Chaudhry V; Griffin JW
    Ann Neurol; 1991 Jul; 30(1):104-6. PubMed ID: 1929221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential high dose intravenous immunoglobulin for demyelinating neuropathy associated with monoclonal IgM gammapathy.
    Desson JF; Hachulla E; Facon T; Fournier Y; Hatron PY; Devulder B
    Eur J Med; 1992 Dec; 1(8):499-50. PubMed ID: 1341212
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic demyelinating polyneuropathy in pregnancy treated with intravenous immunoglobulin.
    Nwosu EC; Tandon S; Breeze C; Enevoldson TP; Khaleeli AA
    Br J Obstet Gynaecol; 1999 Feb; 106(2):174-6. PubMed ID: 10426685
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma exchange in neurology.
    Uldry PA; Steck AJ
    Curr Stud Hematol Blood Transfus; 1990; (57):167-83. PubMed ID: 2272200
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of chronic relapsing inflammatory demyelinating polyradiculoneuropathy: combination of corticosteroids, plasma exchange, and intravenous immunoglobulins.
    Briellmann RS; Nydegger UE; Sturzenegger M; Fierz L; Hess CW; Hauser SP
    Eur Neurol; 1998; 39(3):190-1. PubMed ID: 9605400
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of chronic immune-mediated neuropathies: impact of the rare diseases centers network in Italy.
    Nobile-Orazio E
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S33-8. PubMed ID: 23452770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.